Glucagon-like peptide-1 receptor agonist use increased among eligible patients while metabolic and bariatric surgery rates declined.

Among patients eligible for metabolic and bariatric surgery (MBS), glucagon-like peptide-1 receptor agonist (GLP-1 RA) ...

From 2023, there was a decrease in use of metabolic and bariatric surgery, with stronger decline for sleeve gastrectomy.

Center for Weight Loss Surgery explains the differences between duodenal switch and gastric sleeve surgeries for weight loss.

Bariatric (weight-loss) surgery includes procedures like gastric sleeve, gastric bypass, and biliopancreatic diversion to help individuals with severe obesity (typically BMI, or with co-morbidities) ...

The use of GLP 1s increased dramatically from 2018 to 2025 among patients eligible for metabolic and bariatric surgery in the US, whereas surgery rates declined notably.

Among metabolic and bariatric surgery (MBS)-eligible patients in a national sample, semaglutide and tirzepatide prescriptions ...

A new study suggests bariatric surgery may offer stronger long-term heart protection than GLP-1 drugs like Ozempic and Mounjaro.

Source: Maya Mizrahi and Hadassah Mount Scopus Medical Center/ Used with permission Several randomized controlled trials and meta-analysis have investigated weight loss through hypnosis, finding small ...

Since 2012, TLC's "My 600-lb Life" has followed a year (or longer) in the lives of dozens of morbidly obese people trying to lose weight. Houston surgeon Younan Nowzaradan (aka "Dr. Now") guides these ...